Superpowers for Good

Superpowers for Good

Philanthropist Funds Personalized Research Program For Brain Cancer

Devin D. Thorpe's avatar
Devin D. Thorpe
Oct 30, 2019
∙ Paid

Download the podcast via Apple Podcasts, Google Play or Spotify.

Glioblastoma (GBM) is the most complex and aggressive type of cancer that originates in the brain. There hasn’t been a new FDA approved treatment brought to market in 15 years, and survival rates for GBM have not changed in 30 years – 90% of those diagnosed succumbing to the disease within five years. For the 1.4 million people worldwide living with malignant brain tumors, and an estimated 256,000 that will be diagnosed by the end of the year, this is a grim reality.

Venturing where others have not, the Ivy Brain Tumor Center is taking a completely different approach to personalized care with industry-first clinical trials that are based on:

  • Advanced genetic testing that matches each patient with the best possible treatment.

  • Micro-dosing, which reduces short-term side effects.

  • The combining of FDA approved treatments for GBM with other FDA approved cancer drugs that have never-before been used for brain tumors.

As a result, th…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2026 Devin Thorpe · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for writing, podcasting, and media founders.